SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)
– Order for Approximately $10 Million Funded by the European Commission –
– Orders for Approximately $6 Million Received from Two Countries in the Asia Pacific Region –
Related news for (SIGA)
- Calidi Biotherapeutics Advancing RTNova in Collaboration with SIGA Technologies
- SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer
- SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2023
- SIGA Technologies to Host Business Update Call on May 4th, 2023 Following Release of First Quarter 2023 Financial Results
- SIGA Provides Update on Progress in Clinical Trials to Assess Use of TPOXX ® (tecovirimat) for Treatment of Monkeypox